Company

Ray Therapeutics, Inc.

Biotechnology Research 2607 7th St 31 employees

Employees: 31
Contacts: 4
Emails: 4
Phones: 2

www.raytherapeutics.com LinkedIn Crunchbase

Ray Therapeutics, Inc. Overview

Headquarters: 2607 7th St
Website: www.raytherapeutics.com
Industry: Biotechnology Research
Employees: 31
Founded: 2021
Funding: 8.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

jobs

About Ray Therapeutics, Inc.

Founded in 2021, Ray Therapeutics is a clinical-stage biotechnology company developing best-in-class vision restoration therapies for people with degenerative retinal diseases independent of genetic mutation. We use the innovative technology of optogenetics to reprogram surviving neurons in the retina of the eye to sense light and send visual signals to the brain—restoring vision. We are advancing our pipeline of optogenetic medicines to address a range of degenerative retinal diseases, with programs in both preclinical and clinical stages of development. Ray Therapeutics’ lead candidate, RTX-015, is bioengineered to repurpose retinal ganglion cells to restore vision, and is being evaluated in a Phase 1 trial in Retinitis Pigmentosa and Choroideremia.

Ray Therapeutics, Inc. Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 2; 50.0% coverage

Ray Therapeutics, Inc. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Alonso Guzman	Regulatory Operations and Affairs Professional	United States	Email Phone
Jenny Holt	Chief Development Officer	San Francisco Bay Area, United States	Email Phone
Terry O'neal	C-level Executive with Extensive Operational and Financial Experience, Ranging from Start-ups to Fortune 100 Companies.	Gig Harbor, Washington, United States	Email
Jerrod Denham	VP, Cell & Gene Therapy Tech Ops & Cmc	San Francisco Bay Area, United States	Email